Turner syndrome is a chromosomal disorder usually caused by complete deletion of an X chromosome, with deletion in the short arm of the X chromosome being a rare cause of the condition. Patients with Turner syndrome commonly develop hypertension, and associated vascular complications such as aortic dissection or cerebral hemorrhage have been reported. Cerebral hemorrhage in Turner syndrome is a rare complication, and only a few reports have been published. In these reports, all patients have XO karyotypes or a mosaic type as the cause of Turner syndrome, while no other Turner syndrome types have been documented. In this report, we present for the first time a patient with Turner syndrome caused by deletion in the short arm of the X chromosome who experienced hypertensive hemorrhage as a late complication.

Keywords:
Cerebral hemorrhage, Short-arm deletion, Turner syndrome, X chromosome
1.
Sybert VP, McCauley E: Turner's syndrome. N Engl J Med 2004;351:1227-1238.
2.
Kaiser P, Zabel B, Hansen S, Daume E: Short arm deletion of an X chromosome, 46,XXp-. Hum Genet 1976;32:89-100.
3.
Käosaar M, Mikelsaar AV: Partial short arm deletion of the X chromosome 46,X,del(X)(qter=to p21:). Hum Genet 1980;53:275-277.
4.
Akyürek N, Atabek ME, Eklioglu BS, Alp H: Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000;52:363-370.
5.
Cohen MP, Palutke WA: Gonadal dysgenesis: report of a case with biochemical, histochemical and chromosomal observations. Am J Clin Pathol 1973;60:805-810.
6.
Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF: Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 1986;109:820-826.
7.
Okamoto S, Morimoto Y, Reza MS, Kohso H, Ishikawa M, Takano M, Kurematsu Y, Yamao J, Fukui H: Cerebral hemorrhage in Turner syndrome: a case report. Clin Pediatr Endocrinol 2005;14:35-37.
8.
De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, T'sjoen G, De Backer T: Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J Hypertens 2015;33:1342-1351.
9.
Finsterer J, Zartl M, Samec P: Spontaneous cerebral haemorrhage without hypertension in non-mosaic 45X Turner's syndrome. J Clin Neurosci 2000;7:341-343.
10.
Manjila S, Miller BR, Rao-Frisch A, Otvos B, Mitchell A, Bambakidis NC, De Georgia MA: Moyamoya disease associated with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic stroke. J Stroke Cerebrovasc Dis 2014;23:1242-1244.
11.
Marchini A, Ogata T, Rappold GA: A track record on SHOX: from basic research to complex models and therapy. Endocr Rev 2016;37:417-448.
12.
Mortensen KH, Andersen NH, Gravholt CH: Cardiovascular phenotype in Turner syndrome - integrating cardiology, genetics, and endocrinology. Endocr Rev 2012;33:677-714.
13.
Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, Cravidi C, Vanelli M, Balestrazzi P, Bernasconi S, Giovannelli G: Blood pressure behaviour and control in Turner syndrome. Clin Exp Hypertens A 1986;8:787-791.
14.
Byard RW: Mechanisms of lethal cerebrovascular accidents in Turner syndrome. J Forensic Sci 2016;61:842-844.
15.
Nathwani NC, Unwin R, Brook CG, Hindmarsh PC: Blood pressure and Turner syndrome. Clin Endocrinol 2000;52:363-370.
16.
Fudge EB, Constantacos C, Fudge JC, Davenport M: Improving detection of hypertension in girls with Turner syndrome using ambulatory blood pressure monitoring. Horm Res Paediatr 2014;81:25-31.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.